fluphenazine has been researched along with Psychoses in 186 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results demonstrate that clozapine treatment has potent serotonin antagonist effects in patients with schizophrenia." | 9.07 | Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia. ( Benkelfat, C; Gutierrez-Esteinou, R; Hadd, K; Hsiao, J; Lawlor, BA; Murphy, DL; Owen, RR; Pickar, D, 1993) |
| "The authors' goal was to explore whether clozapine given as the first antipsychotic treatment favorably affects the course of schizophrenia." | 7.72 | Clozapine as a first treatment for schizophrenia. ( Alvir, JM; Kane, JM; Lieberman, JA; Robinson, DG; Sheitman, BB; Woerner, MG, 2003) |
| " A 13-year-old female patient developed hyperprolactinemia with galactorrhea and amenorrhea while receiving thioridazine 300 mg daily." | 7.69 | Attenuation of antipsychotic-induced hyperprolactinemia with clozapine. ( Bunker, MT; Marken, PA; Ruehter, VL; Schneiderhan, ME, 1997) |
| "Eighty hospitalized patients suffering from Schizophrenia or Schizoaffective disorder (male 54, female 26) were first treated with Haloperidol (N=60) or Fluphenazine (N=20), and then were switched to Risperidone." | 5.15 | First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients. ( Popović, I; Popović, V; Ravanić, D; Stanojević, A; Stojanović, M; Vladejić, S, 2011) |
| "Fifty outpatients with schizophrenia or schizoaffective disorder were randomly assigned to receive 25 mg of fluphenazine decanoate intramuscularly either every 2 weeks or every 6 weeks for 54 weeks in a double-blind design." | 5.09 | Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks. ( Breier, AF; Buchanan, RW; Carpenter, WT; Kirkpatrick, B; Lann, HD; Summerfelt, AT, 1999) |
| "Forty-one patients with DSM-III schizophrenia or schizoaffective disorder were assigned to either adjunctive lithium or placebo after at least 6 months of fluphenazine decanoate treatment to stabilize symptoms had failed." | 5.09 | Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatients. ( Glick, ID; Jacobs, M; Ninan, PT; Odbert, CL; Robinson, D; Schulz, SC; Thompson, PA; Weiden, PJ; Yadalam, K, 1999) |
| "These results do not indicate an association between plasma fluphenazine levels and response to treatment or extrapyramidal side effects in first-episode schizophrenia." | 5.07 | Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients. ( Alvir, J; Chakos, M; Cooper, T; Kane, J; Koreen, AR; Lieberman, J; Loebel, A, 1994) |
| "These results demonstrate that clozapine treatment has potent serotonin antagonist effects in patients with schizophrenia." | 5.07 | Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia. ( Benkelfat, C; Gutierrez-Esteinou, R; Hadd, K; Hsiao, J; Lawlor, BA; Murphy, DL; Owen, RR; Pickar, D, 1993) |
| "Fifty-three patients with acute exacerbations of Research Diagnostic Criteria schizophrenic, schizoaffective (mainly schizophrenic), and other nonaffective psychoses completed 24 or 28 days of treatment with randomized, fixed, double-blind doses of 10, 20, or 30 mg of oral fluphenazine hydrochloride daily." | 5.06 | Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. ( Jain, A; Levinson, DF; Silver, P; Simpson, GM; Singh, H; Stephanos, MJ; Yadalam, K, 1990) |
| " All patients had been diagnosed as having schizophrenia or schizoaffective disorder, all were receiving stable doses of fluphenazine decanoate, and all had received benztropine mesylate in an attempt to rule out neuroleptic-induced akinesia." | 5.06 | Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial. ( Cooper, TB; Fagerstrom, R; Morgan, V; Rifkin, A; Siris, SG, 1987) |
| "The risk of adverse side effects of neuroleptic agents must be considered carefully in the treatment of acute and long-term psychotic states." | 3.75 | Antipsychotic drug side effects: their relationship to dose. ( Kane, JM, 1985) |
| "The authors' goal was to explore whether clozapine given as the first antipsychotic treatment favorably affects the course of schizophrenia." | 3.72 | Clozapine as a first treatment for schizophrenia. ( Alvir, JM; Kane, JM; Lieberman, JA; Robinson, DG; Sheitman, BB; Woerner, MG, 2003) |
| "We examined the effect of age on psychopharmacological management in a naturalistic study of a group of 165 patients with a clinical diagnosis of schizophrenia or a related psychotic disorder (age range = 21-84 years; subjects > or = 1;45 years n = 86) treated with either haloperidol decanoate or fluphenazine decanoate." | 3.71 | The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders. ( Chengappa, KN; Jeste, DV; Mamo, DC; Reddy, RR; Sweet, RA, 2002) |
| " A 13-year-old female patient developed hyperprolactinemia with galactorrhea and amenorrhea while receiving thioridazine 300 mg daily." | 3.69 | Attenuation of antipsychotic-induced hyperprolactinemia with clozapine. ( Bunker, MT; Marken, PA; Ruehter, VL; Schneiderhan, ME, 1997) |
| "Eighty-six patients with acute psychotic exacerbations were treated with fixed dosage regimens of oral fluphenazine up to 10-30 mg/day in randomized, double-blind studies." | 2.67 | Acute dystonia during fixed-dose neuroleptic treatment. ( Friedman, E; Levinson, DF; Lo, ES; Simpson, GM; Singh, H, 1990) |
| "The future of depot neuroleptic therapy is discussed in terms of pharmacokinetic and pharmacodynamic research opportunities." | 2.37 | Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches. ( Davis, CM; Ereshefsky, L; Jann, MW; Richards, A; Saklad, SR; Seidel, DR, 1984) |
| "The nature of the psychoses and the significance of the association are discussed." | 1.29 | Prader-Willi syndrome and psychoses. ( Clarke, DJ, 1993) |
| "A patient with schizoaffective disorder and anticholinergic refractory neuroleptic-induced parkinsonism manifested a marked increase of parkinsonian symptoms and dystonia after ECT." | 1.29 | An unusual effect of ECT on drug-induced parkinsonism and tardive dystonia. ( Hanin, B; Lerner, Y; Srour, N, 1995) |
| " This means that it has a long half-life measurable in months rather than weeks." | 1.28 | Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration. ( Cooper, TB; Levinson, DF; Lo, ES; Simpson, GM; Stephanos, MJ; Yadalam, KG, 1990) |
| "Two cases of agranulocytosis occurring after addition of a butyrophenone to a course of phenothiazine treatment are reported and possible mechanisms for this interaction are discussed." | 1.28 | Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment. ( Kehoe, R; Young, A, 1989) |
| "In a fatal case of neuroleptic malignant syndrome, a muscle sample taken within 1 h of death showed acute myopathic features with absence of muscle glycogen and neutral lipid." | 1.27 | Muscle pathology in the neuroleptic malignant syndrome. ( Martin, DT; Swash, M, 1987) |
| "Fluphenazine is shown to be a potent, specific antagonist of the norepinephrine-mediated inhibition of Purkinje cell discharge." | 1.26 | Interactions of antipsychotic drugs with norepinephrine and cerebellar neuronal circuitry: implications for the psychobiology of psychosis. ( Freedman, R, 1977) |
| " Peculiarities of dosage and application, and the position of Depot-Fluphenazin as compared to other Depot-neuroliptics are considered in detail." | 1.25 | [Out-patient treatment of psychoses using depot-fluphenazin]. ( Schmidt, P, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 147 (79.03) | 18.7374 |
| 1990's | 22 (11.83) | 18.2507 |
| 2000's | 9 (4.84) | 29.6817 |
| 2010's | 6 (3.23) | 24.3611 |
| 2020's | 2 (1.08) | 2.80 |
| Authors | Studies |
|---|---|
| Ostuzzi, G | 1 |
| Bertolini, F | 1 |
| Del Giovane, C | 1 |
| Tedeschi, F | 1 |
| Bovo, C | 1 |
| Gastaldon, C | 1 |
| Nosé, M | 1 |
| Ogheri, F | 1 |
| Papola, D | 1 |
| Purgato, M | 1 |
| Turrini, G | 1 |
| Correll, CU | 1 |
| Barbui, C | 1 |
| Patel, RS | 1 |
| Tankersley, WE | 1 |
| Zanker, J | 1 |
| Ferraro, A | 1 |
| Nielssen, O | 1 |
| Fukui, A | 1 |
| Fawkner, L | 1 |
| Walker, K | 1 |
| Rajarethinam, R | 1 |
| Dziuba, J | 1 |
| Manji, S | 1 |
| Pizzuti, A | 1 |
| Lachover, L | 1 |
| Keshavan, M | 1 |
| Zivković, M | 1 |
| Mihaljević-Peles, A | 1 |
| Sagud, M | 1 |
| Silić, A | 1 |
| Mihanović, M | 1 |
| Citrome, L | 1 |
| Jaffe, A | 1 |
| Levine, J | 1 |
| Preskorn, SH | 1 |
| Popović, I | 1 |
| Ravanić, D | 1 |
| Popović, V | 1 |
| Vladejić, S | 1 |
| Stanojević, A | 1 |
| Stojanović, M | 1 |
| Mamo, DC | 1 |
| Sweet, RA | 1 |
| Chengappa, KN | 1 |
| Reddy, RR | 1 |
| Jeste, DV | 1 |
| Woerner, MG | 2 |
| Robinson, DG | 1 |
| Alvir, JM | 2 |
| Sheitman, BB | 1 |
| Lieberman, JA | 2 |
| Kane, JM | 3 |
| DARLING, HF | 1 |
| BARSA, JA | 1 |
| SAUNDERS, JC | 1 |
| MORROW, LE | 1 |
| BAILEY, HR | 1 |
| BLOW, JS | 1 |
| SANDES, SG | 1 |
| SOTELO, D | 1 |
| SMITH, SW | 1 |
| PALMER, B | 1 |
| WACHSMUTH, R | 2 |
| SHAW, CR | 1 |
| LOCKETT, HJ | 1 |
| LUCAS, AR | 1 |
| LAMONTAGNE, CH | 1 |
| GRIMM, F | 1 |
| KURLAND, AA | 2 |
| GRUENWALD, F | 1 |
| VEGA, L | 1 |
| WITTIG, BA | 1 |
| KLINE, NS | 1 |
| SIMPSON, GM | 5 |
| HAEFNER, H | 1 |
| KUTSCHER, I | 1 |
| ECKMANN, F | 1 |
| IMMICH, H | 1 |
| ZIPORYN, M | 1 |
| STONER, HE | 1 |
| ULETT, GA | 1 |
| BOWERS, CA | 1 |
| HEUSLER, AF | 1 |
| QUICK, R | 1 |
| WORD, T | 1 |
| WORD, V | 1 |
| HINDLEY, JP | 1 |
| KERIN, MT | 1 |
| THOMPSON, M | 1 |
| RODRIGUS, E | 1 |
| DE CAMARGO, HA | 1 |
| HOLT, JP | 1 |
| WRIGHT, ER | 1 |
| KOSSOVER, MF | 1 |
| GOLDMAN, AM | 1 |
| Pivac, N | 1 |
| Kozaric-Kovacic, D | 1 |
| Muck-Seler, D | 1 |
| Charles, J | 1 |
| Miller, G | 1 |
| Ng, A | 1 |
| Duggal, HS | 2 |
| Singh, I | 1 |
| Fouks, L | 1 |
| Périvier, E | 1 |
| Houssait, A | 1 |
| Lerno, M | 1 |
| Balon, R | 1 |
| Kabesh, Ia | 1 |
| Papezhova, G | 1 |
| Hofmann, G | 1 |
| Escobar, JI | 1 |
| Barron, A | 1 |
| Kiriakos, R | 1 |
| Dencker, SJ | 1 |
| Ereshefsky, L | 2 |
| Saklad, SR | 2 |
| Jann, MW | 2 |
| Davis, CM | 2 |
| Richards, A | 1 |
| Seidel, DR | 1 |
| Kucharski, LT | 1 |
| Alexander, P | 1 |
| Tune, L | 1 |
| Coyle, J | 1 |
| Glazer, WM | 1 |
| Waldmann, KD | 1 |
| Neumann, J | 1 |
| Mattes, JA | 1 |
| Nayak, D | 1 |
| Harman, AW | 1 |
| Frewin, DB | 1 |
| Priestly, BG | 1 |
| Polácek, J | 1 |
| Goode, DJ | 1 |
| Meltzer, HY | 2 |
| Fang, VS | 1 |
| Yesavage, JA | 2 |
| Fill, NM | 1 |
| Rosenbaum, CP | 1 |
| Rektor, L | 1 |
| Blazek, J | 1 |
| Mauri, MC | 1 |
| Bravin, S | 1 |
| Mantero, M | 1 |
| Invernizzi, G | 1 |
| Guthrie, SK | 1 |
| Stoysich, AM | 1 |
| Bader, G | 1 |
| Hilleman, DE | 1 |
| Siris, SG | 9 |
| Bermanzohn, PC | 1 |
| Mason, SE | 1 |
| Shuwall, MA | 1 |
| Yovell, Y | 1 |
| Opler, LA | 1 |
| Koreen, AR | 1 |
| Lieberman, J | 1 |
| Alvir, J | 1 |
| Chakos, M | 2 |
| Loebel, A | 1 |
| Cooper, T | 1 |
| Kane, J | 1 |
| Clarke, DJ | 1 |
| Owen, RR | 1 |
| Gutierrez-Esteinou, R | 1 |
| Hsiao, J | 1 |
| Hadd, K | 1 |
| Benkelfat, C | 1 |
| Lawlor, BA | 1 |
| Murphy, DL | 1 |
| Pickar, D | 1 |
| Ninan, PT | 2 |
| Shelton, S | 1 |
| Hanin, B | 1 |
| Lerner, Y | 1 |
| Srour, N | 1 |
| Bunker, MT | 1 |
| Marken, PA | 1 |
| Schneiderhan, ME | 1 |
| Ruehter, VL | 1 |
| Benazzi, F | 1 |
| Galynker, I | 1 |
| Ieronimo, C | 1 |
| Perez-Acquino, A | 1 |
| Lee, Y | 1 |
| Winston, A | 1 |
| Robinson, D | 2 |
| Bilder, R | 1 |
| Goldman, R | 1 |
| Geisler, S | 1 |
| Koreen, A | 1 |
| Sheitman, B | 1 |
| Mayerhoff, D | 1 |
| Carpenter, WT | 2 |
| Buchanan, RW | 2 |
| Kirkpatrick, B | 2 |
| Lann, HD | 1 |
| Breier, AF | 1 |
| Summerfelt, AT | 1 |
| Schulz, SC | 1 |
| Thompson, PA | 1 |
| Jacobs, M | 1 |
| Weiden, PJ | 1 |
| Yadalam, K | 2 |
| Glick, ID | 1 |
| Odbert, CL | 1 |
| Gönner, F | 1 |
| Baumgartner, R | 1 |
| Schüpbach, D | 1 |
| Merlo, MC | 1 |
| Siris, S | 1 |
| Pollack, S | 1 |
| Bermanzohn, P | 1 |
| Stronger, R | 1 |
| Al-Sughayir, MA | 1 |
| Gallien, M | 1 |
| Schnetzler, JP | 1 |
| Morin, J | 1 |
| Mason, AS | 1 |
| Granacher, RP | 1 |
| Richou, H | 1 |
| Amdur, MA | 1 |
| Gardos, G | 1 |
| Cole, JO | 2 |
| La Brie, RA | 1 |
| Masson, JA | 1 |
| Bretonneau, CH | 1 |
| Allen, RM | 1 |
| Flemenbaum, A | 1 |
| Jose, C | 1 |
| Mallya, A | 1 |
| Mehta, D | 1 |
| Evenson, R | 1 |
| Holland, R | 1 |
| Blake, B | 1 |
| Guarneri, M | 1 |
| Placidi, GF | 1 |
| Cassano, GB | 1 |
| Yesavage, J | 1 |
| Fill, N | 1 |
| Lapp, D | 1 |
| Becker, J | 1 |
| Mills, M | 1 |
| Bourgeois, M | 1 |
| Freedman, R | 1 |
| Crow, TJ | 1 |
| Deakin, JF | 1 |
| Longden, A | 1 |
| Grunhaus, L | 1 |
| Sancovici, S | 1 |
| Rimon, R | 2 |
| Caroli, F | 1 |
| Littre-Poirier, MF | 1 |
| Ginestet, D | 2 |
| Deniker, P | 1 |
| Peterová, E | 3 |
| Baudis, P | 3 |
| Dvoráková, M | 2 |
| Vencovský, E | 3 |
| Fowler, RC | 1 |
| Kronfol, ZA | 1 |
| Perry, PJ | 1 |
| Crane, DL | 1 |
| Ayd, FJ | 2 |
| Bermejo, E | 1 |
| Rosenstein, DH | 1 |
| Swett, C | 1 |
| Schmidt, P | 2 |
| Hoencamp, E | 1 |
| Haffmans, PJ | 1 |
| Jansen, GS | 1 |
| McClelland, HA | 1 |
| Metcalfe, AV | 1 |
| Kerr, TA | 1 |
| Dutta, D | 1 |
| Watson, P | 1 |
| Robinson, S | 1 |
| Rosca, P | 1 |
| Durst, R | 1 |
| Shai, U | 1 |
| Ghinea, C | 1 |
| Schmidt, U | 1 |
| Nir, I | 1 |
| Singh, H | 3 |
| Levinson, DF | 4 |
| Lo, ES | 2 |
| Friedman, E | 1 |
| Yadalam, KG | 1 |
| Stephanos, MJ | 2 |
| Cooper, TB | 4 |
| Jain, A | 1 |
| Silver, P | 1 |
| Maeda, K | 1 |
| Jauch, D | 1 |
| Tamminga, CA | 1 |
| Frances, A | 1 |
| Mance, RM | 1 |
| Faraone, SV | 1 |
| Green, AI | 1 |
| Brown, W | 1 |
| Yin, P | 1 |
| Tsuang, MT | 1 |
| Young, A | 1 |
| Kehoe, R | 1 |
| Aronson, A | 2 |
| Sellew, AP | 1 |
| Adan, F | 3 |
| Cutler, J | 1 |
| Owen, K | 1 |
| Mason, S | 1 |
| Gingerich, S | 1 |
| Lang, MP | 1 |
| Kolakowska, T | 2 |
| Williams, AO | 2 |
| Ardern, M | 2 |
| Reveley, MA | 1 |
| Jambor, K | 1 |
| Gelder, MG | 1 |
| Mandelbrote, BM | 1 |
| Teicher, MH | 1 |
| Baldessarini, RJ | 1 |
| Van Putten, T | 1 |
| Marder, SR | 1 |
| Turns, DM | 1 |
| Pary, R | 1 |
| Tobias, CR | 1 |
| James, WA | 1 |
| Genz, A | 1 |
| Cohen, M | 1 |
| Mandeli, J | 2 |
| Casey, E | 2 |
| Strahan, A | 2 |
| Lee, A | 1 |
| Laska, EV | 1 |
| Midha, KK | 1 |
| Martin, DT | 1 |
| Swash, M | 1 |
| Munetz, MR | 1 |
| Ginchereau, EH | 1 |
| Toenniessen, LM | 1 |
| Rampertaap, MP | 1 |
| Coffman, JA | 1 |
| Nasrallah, HA | 1 |
| Lyskowski, J | 1 |
| McCalley-Whitters, M | 1 |
| Dunner, FJ | 1 |
| Morgan, V | 1 |
| Fagerstrom, R | 1 |
| Rifkin, A | 2 |
| Blum, A | 1 |
| Hinterhuber, H | 1 |
| Neumann, R | 1 |
| Reardon, GT | 1 |
| Doddi, SR | 1 |
| Hall, KS | 1 |
| Zabow, T | 1 |
| Richards, AL | 1 |
| Burch, NR | 1 |
| Kellner, C | 1 |
| Harris, P | 1 |
| Blumhardt, C | 1 |
| Ropert, R | 1 |
| Lévy, L | 1 |
| Ropert, M | 1 |
| Escande, M | 1 |
| Vasquez Villareal, S | 1 |
| Gayral, L | 2 |
| Oules, J | 1 |
| Fourny, L | 1 |
| Grandmontagne, O | 1 |
| Millet, L | 1 |
| Peretti, A | 1 |
| Roux, G | 1 |
| Durou, B | 1 |
| Ban, TA | 1 |
| Lehmann, HE | 1 |
| Pellet, J | 1 |
| Guyotat, J | 1 |
| Marie-Cardine, M | 1 |
| Dubor, P | 1 |
| Favre-Tissot, M | 1 |
| Caron, F | 1 |
| Cottraux, J | 1 |
| Sachar, EJ | 1 |
| Frantz, AG | 1 |
| Asparre, Y | 1 |
| Guilyardi, O | 1 |
| Anderson, WH | 1 |
| Kuehnle, JC | 1 |
| Chien, CP | 1 |
| Martin, A | 1 |
| Masson, JM | 1 |
| Quentin, JC | 1 |
| Verrier, JP | 1 |
| Jusseaume, P | 1 |
| van Praag, HM | 1 |
| Dols, LC | 1 |
| Bakke, O | 1 |
| Martin, IC | 1 |
| Townend, RA | 1 |
| Bastie, Y | 1 |
| Schwingenheuer, J | 1 |
| Péron-Magnan, P | 1 |
| Haslam, MT | 1 |
| Schoonmaker, JB | 1 |
| Kinzie, JD | 1 |
| Bolton, JM | 1 |
| Janovský, F | 1 |
| Thornton, WE | 1 |
| Thornton, BP | 1 |
| Sims, A | 1 |
| White, A | 1 |
| Yorke, ET | 1 |
| Keskiner, A | 1 |
| Simeon, J | 1 |
| Fink, M | 1 |
| Itil, TM | 1 |
| Gunby, B | 1 |
| Brun, H | 1 |
| Hartviksen, I | 1 |
| Engstrand, E | 1 |
| Kehoe, MJ | 1 |
| Whittier, JR | 1 |
| Korenyi, C | 1 |
| Haydu, GG | 1 |
| Goldschmidt, L | 1 |
| Karkalas, Y | 1 |
| Baldini, JT | 1 |
| Neary, ER | 1 |
| Svestka, J | 2 |
| Náhunek, K | 2 |
| Haumonté, MT | 2 |
| Hoerdt, HP | 1 |
| Haring, C | 1 |
| Hanlon, TE | 1 |
| Michaux, MH | 1 |
| Ota, KY | 1 |
| Shaffer, JW | 1 |
| Verster, JP | 1 |
| Denzel, HA | 1 |
| Christiani, K | 1 |
| Sedivec, V | 1 |
| Wurtz, D | 1 |
| Jacquot, MP | 1 |
| Faretra, G | 1 |
| Dooher, L | 1 |
| Dowling, J | 1 |
| Boissenin, JM | 1 |
| Staël, P | 1 |
| Poiré, R | 1 |
| Rodová, A | 1 |
| Auch, W | 1 |
| Borenstein, P | 2 |
| Dumaine, A | 2 |
| Cujo, P | 2 |
| Lustig, B | 1 |
| Lambert, PA | 2 |
| Midenet, M | 1 |
| Marcou, G | 2 |
| Bouchardy, M | 2 |
| Pfeiffer, WM | 1 |
| Langner, E | 1 |
| Eichstetter, F | 1 |
| Glatzel, J | 1 |
| Stewart, AR | 1 |
| Lavallee, B | 1 |
| Ucha Udabe, R | 1 |
| Gonzalez, JR | 1 |
| Petrilowitsch, N | 1 |
| Herzog, R | 1 |
| Sutter, JM | 1 |
| Debrie, ML | 1 |
| Scotto, JC | 1 |
| Stenbäck, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| ExPRESS:2 (Experiences of Psychosis Relapse: Early Subjective Signs) Longitudinal Feasibility Study[NCT03558529] | 27 participants (Actual) | Observational | 2015-05-01 | Completed | |||
| Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia[NCT00595504] | Phase 4 | 25 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia[NCT03075657] | Phase 4 | 120 participants (Actual) | Interventional | 2017-05-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A comparison between the ramelteon group and the placebo group of change in abdominal fat measured by a DEXA scan, assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | g (Mean) |
|---|---|
| Ramelteon | 3934.86 |
| Placebo (Sugar Pill) | 5120.92 |
A comparison between the ramelteon group and the placebo group of change in insulin resistance measured by the homeostatic model assessment of insulin resistance (HOMA-IR), assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | HOMA score (Mean) |
|---|---|
| Ramelteon | 2.4 |
| Placebo (Sugar Pill) | 2.36 |
A comparison between the ramelteon group and the placebo group in change in waist circumference (measured in cm) measured at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | cm (Mean) |
|---|---|
| Ramelteon | 106.09 |
| Placebo (Sugar Pill) | 108.37 |
11 reviews available for fluphenazine and Psychoses
| Article | Year |
|---|---|
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphen | 2021 |
CNS drug development. Part I: The early period of CNS drugs.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Central | 2010 |
[COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA].
Topics: Agranulocytosis; Autonomic Nervous System Diseases; Chemical and Drug Induced Liver Injury; Chlorpro | 1964 |
Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.
Topics: Adult; Antipsychotic Agents; Biological Availability; Chromatography; Delayed-Action Preparations; F | 1984 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Sche | 1984 |
The depot fluphenazines: a reappraisal after 10 years' clinical experience.
Topics: Administration, Oral; Adult; Age Factors; Aged; Ambulatory Care; Basal Ganglia Diseases; Child; Dela | 1975 |
Antipsychotic drug side effects: their relationship to dose.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Respon | 1985 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, | 1986 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differ | 1986 |
II. Major tranquilizers.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chlordiazepoxide; Chlorpromazine; Fluphenazine; Hem | 1971 |
39 trials available for fluphenazine and Psychoses
| Article | Year |
|---|---|
First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Substitution; F | 2011 |
Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Dose-Response Relationship, Dr | 2004 |
A controlled study of neuroleptization with fluphenazine hydrochloride injections.
Topics: Brief Psychiatric Rating Scale; Clinical Trials as Topic; Double-Blind Method; Fluphenazine; Humans; | 1983 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Sche | 1984 |
Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial.
Topics: Adult; Antipsychotic Agents; Benztropine; Delayed-Action Preparations; Depressive Disorder; Double-B | 1994 |
Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Basal Ganglia Diseases; Chronic Disease; Drug Administ | 1994 |
Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
Topics: Adult; Body Temperature; Clozapine; Female; Fluphenazine; Hospitalization; Humans; Hydrocortisone; I | 1993 |
Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.
Topics: Adult; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Fluph | 1999 |
Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatients.
Topics: Ambulatory Care; Brief Psychiatric Rating Scale; Drug Therapy, Combination; Fluphenazine; Humans; Li | 1999 |
Adjunctive imipramine for a broader group of post-psychotic depressions in schizophrenia.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benztropine; Depressive Disorder, Maj | 2000 |
Fluphenazine decanoate: fifty cases over seven years--a report.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; Middle Aged; Psycho | 1978 |
[Trial of interruption of antiparkinson drugs in long term treatments with neuroleptics].
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Fluph | 1975 |
Haloperidol in psychiatry.
Topics: Anxiety Disorders; Basal Ganglia Diseases; Clinical Trials as Topic; Dopamine Antagonists; Fluphenaz | 1975 |
Acute dystonia during fixed-dose neuroleptic treatment.
Topics: Adult; Amobarbital; Chloral Hydrate; Dose-Response Relationship, Drug; Drug Administration Schedule; | 1990 |
Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment.
Topics: Acute Disease; Akathisia, Drug-Induced; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Dr | 1990 |
Neuroleptic dose reduction in persistently psychotic patients.
Topics: Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluph | 1989 |
Imipramine-responsive panic-like symptomatology in schizophrenia/schizoaffective disorder.
Topics: Adult; Benztropine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fear; | 1989 |
Antipsychotic drug side effects: their relationship to dose.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Respon | 1985 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, | 1986 |
Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
Topics: Adolescent; Adult; Aged; Benztropine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1988 |
Clinical effectiveness of oral and parenteral rapid neuroleptization.
Topics: Acute Disease; Administration, Oral; Adult; Clinical Trials as Topic; Double-Blind Method; Drug Admi | 1987 |
Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination | 1987 |
Efficacy of haloperidol in drug refractory patients.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Female; Fluphenazine; Haloperidol; Humans; M | 1967 |
Depot phenothiazine treatment in acute psychosis: a sequential comparative clinical study.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antiparkinson Agents; Basal Ganglia Diseases | 1973 |
[Comparative study of the action of fluphenazine oenanthate and decanoate in chronic psychoses (73 cases)].
Topics: Adult; Bipolar Disorder; Clinical Trials as Topic; Female; Fluphenazine; Humans; Middle Aged; Psycho | 1972 |
Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.
Topics: Acute Disease; Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Esters; Female; Fluphenazine; | 1973 |
Clinical experience with depot neuroleptics.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Drug Therapy, Combin | 1973 |
Implications of sustained release phenothiazines: a study of fluphenazine decanoate.
Topics: Adult; Aged; Behavior; Clinical Trials as Topic; Delayed-Action Preparations; Female; Fluphenazine; | 1974 |
[Outcome in 64 chronic psychotics treated with delayed action Moditen or Modecate].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Delusions; Drug Evalu | 1974 |
Use of oral and injectable phenothiazines in treatment of psychotic patients.
Topics: Adult; Catatonia; Clinical Trials as Topic; Female; Fluphenazine; Humans; Injections, Intramuscular; | 1967 |
Long-acting phenothiazine (fluphenazine decanoate) treatment of psychosis.
Topics: Adult; Clinical Trials as Topic; Extrapyramidal Tracts; Female; Fluphenazine; Hospitalization; Hospi | 1968 |
Fluphenazine in the long term treatment of psychoses. A preliminary communication.
Topics: Adolescent; Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Female; Fluphenazine; Humans; Mal | 1968 |
[Fluphenazine enanthate in long term treatment of psychoses].
Topics: Clinical Trials as Topic; Fluphenazine; Humans; Male; Parkinson Disease, Secondary; Psychotic Disord | 1969 |
Effects of long-acting injectable Prolixin in 23 psychotic patients.
Topics: Adult; Aged; Drug Evaluation; Female; Fluphenazine; Humans; Injections; Middle Aged; Placebos; Psych | 1967 |
Controlled trials of an amitriptyline-fluphenazine combination in depressive neuroses and psychoses: a collaborative study.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clinical Trials as Topic; Depression; Fluphenazine; Humans; | 1970 |
The comparative effectiveness of eight phenothiazines.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; Mid | 1965 |
A clinical evaluation of an injectable phenothiazine in the management of acute psychotic patients.
Topics: Clinical Trials as Topic; Fluphenazine; Humans; Psychotic Disorders; Schizophrenia | 1967 |
Fluphenazine enanthate in the treatment of psychotic patients.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; Middle Aged; Psycho | 1966 |
140 other studies available for fluphenazine and Psychoses
| Article | Year |
|---|---|
Real-world effectiveness of long-acting injectable antipsychotics to reduce 90-day and annual readmission in psychotic disorders: insights from a state psychiatric hospital.
Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Fluphenazine; Hos | 2022 |
Consequences of market withdrawal of fluphenazine and trifluoperazine: Letter to the editor and case series.
Topics: Aged; Antipsychotic Agents; Drug Recalls; Female; Fluphenazine; Humans; Male; Psychotic Disorders; S | 2017 |
Va'a fakalelei 'atamai: restoring the mind in the Kingdom of Tonga.
Topics: Fluphenazine; Kava; Mental Health Services; Psychotic Disorders; Tonga | 2014 |
Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Sch | 2009 |
The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
Topics: Adult; Alleles; Antipsychotic Agents; Bipolar Disorder; Clozapine; Cytochrome P-450 CYP2D6; Dibenzot | 2010 |
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relati | 2010 |
The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Dose | 2002 |
Clozapine as a first treatment for schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Female; Fluphenazi | 2003 |
Fluphenazine: a preliminary study.
Topics: Fluphenazine; Phenothiazines; Psychosurgery; Psychotic Disorders | 1959 |
Fluphenazine use with chronic psychotic patients.
Topics: Electroconvulsive Therapy; Fluphenazine; Mental Disorders; Psychosurgery; Psychotic Disorders; Tranq | 1961 |
Fluphenazine in private psychiatric practice.
Topics: Electroconvulsive Therapy; Fluphenazine; Psychotherapy; Psychotic Disorders; Tranquilizing Agents | 1961 |
"Siqualine" (fluphenazine) in psychiatric practice: a preliminary report.
Topics: Counseling; Fluphenazine; Humans; Psychotherapy; Psychotic Disorders; Tranquilizing Agents | 1960 |
Fluphenazine for chronic psychotic patients.
Topics: Chronic Disease; Fluphenazine; Humans; Mental Disorders; Psychotic Disorders | 1963 |
[Problems in psychiatric pharmacotherapy and the role of fluphenazine in the treatment of psychoses].
Topics: Fluphenazine; Mental Disorders; Psychosurgery; Psychotic Disorders; Tranquilizing Agents | 1962 |
TRANQUILIZER DRUGS IN THE TREATMENT OF EMOTIONALLY DISTURBED CHILDREN. I. INPATIENTS IN A RESIDENTIAL TREATMENT CENTER.
Topics: Antidepressive Agents; Antisocial Personality Disorder; Benactyzine; Brain; Brain Damage, Chronic; C | 1963 |
FLUPHENAZINE (PROLIXIN) ENANTHATE-A PHENOTHIAZINE PREPARATION OF PROLONGED ACTIVITY.
Topics: Biomedical Research; Drug Tolerance; Fluphenazine; Heptanoates; Mental Disorders; Pharmacology; Phen | 1964 |
A LONG-ACTING PHENOTHIAZINE IN OFFICE PRACTICE.
Topics: Bipolar Disorder; Extrapyramidal Tracts; Fluphenazine; Paranoid Disorders; Phenothiazines; Psychotic | 1964 |
[NEUROLEPTICS AND DYSKINETIC REACTIONS].
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Chlorprothixene; Depression; Fluphenazine; M | 1963 |
THE USE OF FLUPHENAZINE HYDROCHLORIDE (PROLIXIN) IN ACUTE FUNCTIONAL PSYCHOSES.
Topics: Bipolar Disorder; Drug Therapy; Fluphenazine; Psychoses, Alcoholic; Psychotic Disorders; Schizophren | 1964 |
A STUDY OF THE BEHAVIOR AND EEG PATTERNS OF PATIENTS RECEIVING TRANQUILIZERS WITH AND WITHOUT THE ADDITION OF CHLORDIAZEPOXIDE.
Topics: Bipolar Disorder; Chlordiazepoxide; Drug Synergism; Drug Therapy; Electroencephalography; Fluphenazi | 1964 |
COMPARISON OF THREE PHENOTHIAZINES ON CHRONIC PSYCHOTIC BEHAVIOR.
Topics: Aggression; Anxiety; Chlorpromazine; Drug Therapy; Fluphenazine; Mental Disorders; Muscle Relaxants, | 1965 |
[TREATMENT OF A GROUP OF PSYCHOTIC PATIENTS WITH FLUPHENAZINE].
Topics: Fluphenazine; Humans; Mental Disorders; Psychotic Disorders | 1964 |
[FLUPHENAZINE IN THE TREATMENT OF PSYCHOSES. RESULTS IN 100 CASES].
Topics: Drug Therapy; Fluphenazine; Humans; Mental Disorders; Psychotic Disorders | 1965 |
Preliminary results with fluphenazine (prolixin) in chronic psychotic patients.
Topics: Electroconvulsive Therapy; Fluphenazine; Mental Disorders; Psychotic Disorders; Tranquilizing Agents | 1960 |
Clinical experience with fluphenazine (Prolixin) a new phenothiazine drug.
Topics: Fluphenazine; Humans; Phenothiazines; Psychotic Disorders | 1961 |
[On the treatment of psychotic patients with fluphenazine].
Topics: Fluphenazine; Mental Disorders; Phenothiazines; Psychotic Disorders | 1961 |
Management of psychosis in Australian general practice.
Topics: Adolescent; Adult; Age Factors; Aged; Antimanic Agents; Antipsychotic Agents; Australia; Benzodiazep | 2006 |
Glycopyrrolate for clozapine-induced sialorrhea.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Clozapine; Fluphenazine; Glycopyrrolate; Humans; Male | 2007 |
Neuroleptic malignant syndrome presenting with acute renal failure.
Topics: Acute Kidney Injury; Antipsychotic Agents; Benzodiazepines; Electroencephalography; Female; Fluphena | 2008 |
[Indications and modes of administration of fluphenazine enanthate].
Topics: Fluphenazine; Humans; Injections; Orphenadrine; Parasympathomimetics; Psychotic Disorders; Trihexyph | 1967 |
[Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
Topics: Adult; Antipsychotic Agents; Dibenzothiepins; Double-Blind Method; Female; Fluphenazine; Humans; Mal | 1982 |
The clinical and therapeutical aspects of schizo-affective psychosis.
Topics: Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Delusions; Diagnosis, Differential; D | 1983 |
The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Topics: Administration, Oral; Antipsychotic Agents; Basal Ganglia Diseases; Biological Availability; Chronic | 1984 |
Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Benztropine; Female; Fluphenazine; Haloperidol; Humans; Mal | 1984 |
[Clinical experience with depot neuroleptic treatment].
Topics: Female; Fluphenazine; Hallucinations; Humans; Male; Prognosis; Psychotic Disorders; Schizophrenia; S | 1984 |
Lithium versus fluphenazine for prophylaxis in mainly schizophrenic schizo-affectives.
Topics: Adolescent; Adult; Double-Blind Method; Drug Therapy, Combination; Fluphenazine; Humans; Lithium; Mi | 1984 |
Comparative enzyme-inducing effects of chlorpromazine and fluphenazine therapies in psychotic patients.
Topics: Adult; Aged; Antipyrine; Chlorpromazine; Enzyme Induction; Female; Fluphenazine; Half-Life; Humans; | 1980 |
[Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
Topics: Adult; Aged; Ambulatory Care; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Middl | 1982 |
Daytime variation in serum prolactin level in patients receiving oral and depot antipsychotic medication.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Female; Fluphenazine; Humans; Male; Prolactin; Psychotic Di | 1981 |
Psychopharmacology in the setting of a psychiatric intensive care unit.
Topics: Acute Disease; Fluphenazine; Humans; Intensive Care Units; Psychiatric Department, Hospital; Psychot | 1980 |
[Results of treatment by Moditen Depot in outpatients' wards in the South Moravian Region (author's transl)].
Topics: Ambulatory Care; Delayed-Action Preparations; Fluphenazine; Humans; Psychotic Disorders | 1980 |
Depression in schizophrenia: clinical and pharmacological variables.
Topics: Adolescent; Adult; Age Factors; Aged; Depressive Disorder; Dexamethasone; Female; Fluphenazine; Halo | 1995 |
Hypothesized interaction between valproic acid and warfarin.
Topics: Aged; Blood Coagulation Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug | 1995 |
Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis.
Topics: Adult; Clozapine; Cocaine; Comorbidity; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Flu | 1994 |
Prader-Willi syndrome and psychoses.
Topics: Adolescent; Adult; Age of Onset; Chlorpromazine; Chromosome Aberrations; Chromosome Disorders; Chrom | 1993 |
Managing psychotic symptoms when the diagnosis is unclear.
Topics: Adult; Diagnosis, Differential; Fluoxetine; Fluphenazine; Humans; Male; Obsessive-Compulsive Disorde | 1993 |
An unusual effect of ECT on drug-induced parkinsonism and tardive dystonia.
Topics: Adult; Antipsychotic Agents; Dystonia; Electroconvulsive Therapy; Fluphenazine; Humans; Male; Parkin | 1995 |
Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
Topics: Adolescent; Amenorrhea; Antipsychotic Agents; Bromocriptine; Clozapine; Female; Fluphenazine; Galact | 1997 |
Spiramycin-associated acute dystonia during neuroleptic treatment.
Topics: Adult; Anti-Bacterial Agents; Antipsychotic Agents; Delayed-Action Preparations; Drug Therapy, Combi | 1997 |
Panic attacks with psychotic features.
Topics: Adult; Age of Onset; Auditory Perception; Benzodiazepines; Comorbidity; Delusions; Diagnosis, Differ | 1996 |
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Cohort Studies; Female; Fluphenazine; Follow-Up Studies; Ha | 1999 |
Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.
Topics: Adult; Antipsychotic Agents; Clozapine; Dantrolene; Female; Fluphenazine; Humans; Muscle Relaxants, | 1999 |
Depot antipsychotics. Patient characteristics and prescribing pattern.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Utiliz | 2000 |
[Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients].
Topics: Adult; Aged; Antibodies, Antinuclear; Antipsychotic Agents; Chlorpromazine; Dementia; Female; Fluphe | 1975 |
Basic principles of rapid neuroleptization.
Topics: Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Fluphenazine; Ha | 1976 |
[Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice].
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Middle | 1975 |
Frequent questions about long-acting, injectable fluphenazine.
Topics: Delayed-Action Preparations; Fluphenazine; Humans; Injections; Psychotic Disorders | 1978 |
Drug variables in the etiology of tardive dyskinesia application of discriminant function analysis.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Male; Mid | 1977 |
Delirium associated with combined fluphenazine-clonidine therapy.
Topics: Adult; Clonidine; Delirium; Drug Therapy, Combination; Fluphenazine; Humans; Hypertension; Male; Psy | 1979 |
Iatrogenic morbidity in patients taking depot fluphenazine.
Topics: Adult; Age Factors; Aged; Akathisia, Drug-Induced; Basal Ganglia Diseases; Delayed-Action Preparatio | 1979 |
Depot neuroleptics in a community mental health service.
Topics: Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Psychotic Disorders; | 1979 |
Depot neuroleptics in the treatment of acute psychoses.
Topics: Acute Disease; Adult; Aged; Chlorpromazine; Delayed-Action Preparations; Female; Fluphenazine; Human | 1979 |
[Psychopathology and treatment of violent psychotics in the United States].
Topics: California; Dangerous Behavior; Family; Fluphenazine; Humans; Psychotic Disorders; Surveys and Quest | 1979 |
Interactions of antipsychotic drugs with norepinephrine and cerebellar neuronal circuitry: implications for the psychobiology of psychosis.
Topics: Action Potentials; Afferent Pathways; Animals; Cerebellum; Dose-Response Relationship, Drug; Drug An | 1977 |
The nucleus accumbens--possible site of antipsychotic action of neuroleptic drugs?
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benztropine; Chlorpromazine; Corpus Striatum; Dopamine; Dos | 1977 |
Neuroleptic malignant syndrome due to depot fluphenazine.
Topics: Adult; Coma; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Fever; Fluphenazine; Humans; Mal | 1979 |
[Clinical experiences with depot neuroleptics].
Topics: Delayed-Action Preparations; Depressive Disorder, Major; Female; Flupenthixol; Fluphenazine; Humans; | 1975 |
Water intoxication, psychosis, and inappropriate secretion of antidiuretic hormone.
Topics: Delusions; Drinking Behavior; Fluphenazine; Humans; Hydrochlorothiazide; Male; Middle Aged; Psychoti | 1977 |
More violent Capgras.
Topics: Adult; Delusions; Fluphenazine; Humans; Male; Perceptual Disorders; Psychotic Disorders; Violence | 1976 |
Therapy with injectable fluphenazines.
Topics: Acute Disease; Age Factors; Ambulatory Care; Basal Ganglia Diseases; Chronic Disease; Delayed-Action | 1976 |
[Direct treatment of psychotic symptoms with an incisive neuroleptic (Dapotum Acutum)].
Topics: Adult; Aged; Drug Evaluation; Fluphenazine; Humans; Injections, Intramuscular; Injections, Intraveno | 1976 |
Using community psychiatry methods in private practice.
Topics: Adult; Community Mental Health Services; Community Psychiatry; Female; Fluphenazine; Humans; Mental | 1975 |
Drug-induced dystonia.
Topics: Adjustment Disorders; Adult; Basal Ganglia Diseases; Chlorpromazine; Chlorprothixene; Female; Fluphe | 1975 |
[Out-patient treatment of psychoses using depot-fluphenazin].
Topics: Adult; Aged; Ambulatory Care; Drug Administration Schedule; Drug Evaluation; Female; Fluphenazine; H | 1975 |
Lowest effective dose of depot neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationsh | 1992 |
Facial dyskinesia: a 16-year follow-up study.
Topics: Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Brain; Chlorpromazine; Dose-Response Rel | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Depressive Disorder; Drug Therapy, Combination; Female; Flu | 1991 |
Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Fluphenazine; Haloperidol; Humans; Injections, In | 1990 |
Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
Topics: Adult; Antipsychotic Agents; Brain; Female; Fluphenazine; Haloperidol; Humans; Male; Prolactin; Psyc | 1989 |
Treating a psychotic woman with changing symptoms.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Female; Fluphenazine; Halluc | 1989 |
Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment.
Topics: Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Clomipramine; Depressive Disorder; Dose-Respo | 1989 |
Trials of adjunctive alprazolam in "negative symptom" patients.
Topics: Adult; Alprazolam; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Hallucinations; Hum | 1989 |
Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression.
Topics: Adult; Benztropine; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Fluphenazin | 1989 |
Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Brain; Chlorpromazine; Cognition Disorders; Femal | 1985 |
Selection of neuroleptic dosage.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; | 1985 |
Tardive dyskinesia and current dose of neuroleptic drugs.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixo | 1985 |
Depot neuroleptics for acutely psychotic patients.
Topics: Acute Disease; Antipsychotic Agents; Fluphenazine; Haloperidol; Humans; Psychotic Disorders | 1987 |
[Tardive dystonia--a case report on therapy and metaphylaxis].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Fluphena | 1988 |
Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
Topics: Benztropine; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Humans; Imipramine; Psych | 1988 |
Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Topics: Adult; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug T | 1988 |
Neuroleptic plasma level may predict response in patients who meet a criterion for improvement.
Topics: Fluphenazine; Humans; Psychotic Disorders | 1988 |
Muscle pathology in the neuroleptic malignant syndrome.
Topics: Adult; Fluphenazine; Humans; Male; Muscles; Neuroleptic Malignant Syndrome; Procyclidine; Psychotic | 1987 |
Tardive dyskinesia complicated by hyperthyroidism.
Topics: Adult; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Psychotic Disorders; Thyrotoxicosis | 1987 |
Is postpsychotic depression a primary affective disorder?
Topics: Depressive Disorder; Fluphenazine; Humans; Psychotic Disorders; Schizophrenia | 1986 |
[Depressive syndromes within the scope of schizophrenic psychoses].
Topics: Depressive Disorder; Fluphenazine; Hallucinations; Humans; Long-Term Care; Male; Models, Psychologic | 1985 |
Stability of the postpsychotic depression syndrome.
Topics: Adult; Depressive Disorder; Female; Fluphenazine; Humans; Male; Middle Aged; Outcome and Process Ass | 1986 |
Experience with fluphenazine hydrochloride injection.
Topics: Fluphenazine; Humans; Injections; Psychotic Disorders | 1985 |
Effects of smoking on fluphenazine clearance in psychiatric inpatients.
Topics: Adult; Female; Fluphenazine; Humans; Kinetics; Male; Metabolic Clearance Rate; Psychotic Disorders; | 1985 |
Concurrent use of bromocriptine and fluphenazine.
Topics: Adenoma, Chromophobe; Bromocriptine; Drug Interactions; Drug Therapy, Combination; Fluphenazine; Hum | 1985 |
[Problems of use trials of long-acting tranquilizers in acute psychiatric syndromes].
Topics: Acute Disease; Adult; Antipsychotic Agents; Female; Fluphenazine; Humans; Male; Middle Aged; Piperid | 1973 |
[Incidents and accidents during therapy with long-acting neuroleptics].
Topics: Amenorrhea; Autonomic Nervous System; Body Weight; Delayed-Action Preparations; Depression; Eye Mani | 1974 |
[New method of chemotherapy in psychiatry with a neuroleptic with prolonged effect: fluphenazine enanthate].
Topics: Fluphenazine; Humans; Psychotic Disorders; Schizophrenia | 1968 |
[Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
Topics: Alcoholism; Antipsychotic Agents; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine | 1972 |
Serum prolactin levels in newly admitted psychiatric patients.
Topics: Acute Disease; Bipolar Disorder; Chicago; Chlorpromazine; Chronic Disease; Depression; Dose-Response | 1974 |
[A case of erotomania delusion. Attempt of syntax analysis of the delusional speech. A new way to question platonism in erotomania].
Topics: Adult; Delusions; Dreams; Female; Fluphenazine; Humans; Interpersonal Relations; Language; Love; Par | 1974 |
Strategies for the treatment of acute psychosis.
Topics: Acute Disease; Alcohol Amnestic Disorder; Cooperative Behavior; Emergencies; Female; Fluphenazine; H | 1974 |
[Clinical experiences with a delayed-action preparation of fluphenazine].
Topics: Administration, Oral; Adult; Aged; Basal Ganglia Diseases; Bipolar Disorder; Climacteric; Delayed-Ac | 1972 |
[Long-action neuroleptic agents (delayed-action neuroleptics)].
Topics: Age Factors; Delayed-Action Preparations; Delirium; Fever; Fluphenazine; Hallucinations; Humans; Mov | 1972 |
A case of Capgras syndrome.
Topics: Adult; Affective Symptoms; Delayed-Action Preparations; Delusions; Female; Fluphenazine; Humans; Psy | 1973 |
Danger of depot phenothiazine treatment in acute psychosis.
Topics: Delayed-Action Preparations; Drug Hypersensitivity; Fluphenazine; Humans; Leukopenia; Psychotic Diso | 1973 |
Psychiatry with the aborigines of West Malaysia.
Topics: Adolescent; Adult; Culture; Ethnicity; Female; Fluphenazine; Hospitalization; Hospitals; Humans; Mal | 1973 |
A contribution to the maintenance therapy with depot neuroleptic drugs.
Topics: Female; Fluphenazine; Humans; Male; Psychotic Disorders | 1973 |
Letter: Tardive dyskinesia and low dosage.
Topics: Chlorpromazine; Fluphenazine; Humans; Hypnotics and Sedatives; Movement Disorders; Promethazine; Psy | 1973 |
Coexistence of the Capgras and de Clérambault syndromes. A case history.
Topics: Adult; Affective Symptoms; Attitude; Chlorpromazine; Delusions; Female; Fluphenazine; Humans; Mother | 1973 |
Fluphenazine enanthate: a report of a clinical trial in psychotic patients.
Topics: Adult; Aged; Bipolar Disorder; Fluphenazine; Humans; Middle Aged; Psychotic Disorders; Schizophrenia | 1968 |
Flupenthixol depot in the maintenance treatment of psychoses.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Butyrophenones; Delayed-Action Preparations; Ethano | 1972 |
[Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
Topics: Adult; Delayed-Action Preparations; Drug Tolerance; Fluphenazine; Hallucinations; Humans; Hypochondr | 1972 |
[Delayed-action preparation therapy as a possibility in social rehabilitation].
Topics: Delayed-Action Preparations; Female; Fluphenazine; Humans; Psychotic Disorders; Tranquilizing Agents | 1972 |
[Experience with a new depot neuroleptic].
Topics: Adult; Fluphenazine; Humans; Male; Psychotic Disorders; Schizophrenia; Time Factors | 1969 |
[Clinical experience with fluphenazine Depot].
Topics: Adult; Depressive Disorder, Major; Fluphenazine; Humans; Middle Aged; Paranoid Disorders; Psychotic | 1970 |
[Action of fluphenazine and benzperidol on psychologic tests (Rorschach) of psychotic patients].
Topics: Adult; Benperidol; Fluphenazine; Humans; Male; Psychotic Disorders; Rorschach Test | 1970 |
Comparison of haloperidol and fluphenazine in disturbed children.
Topics: Aggression; Anxiety; Autistic Disorder; Child; Child, Preschool; Female; Fluphenazine; Haloperidol; | 1970 |
[Is it possible to envisage the treatment of various potentially dangerous states with prolonged-action chemotherapy?].
Topics: Delayed-Action Preparations; Fluphenazine; Humans; Male; Middle Aged; Psychotic Disorders | 1970 |
[Clinical experience with fluphenazine decanoate in psychoses].
Topics: Adolescent; Adult; Depressive Disorder, Major; Female; Fluphenazine; Humans; Male; Middle Aged; Para | 1970 |
[The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Delayed-Action Preparations; Fluphenazine; Humans; | 1970 |
[Clinical and biological effects of fluphénazine décanoate. 35 cases].
Topics: Anxiety; Blood Pressure; Chronic Disease; Extrapyramidal Tracts; Fluphenazine; Humans; Psychotic Dis | 1970 |
[Electroencephalographic effects of fluphonazine decanoate].
Topics: Brain; Electroencephalography; Fluphenazine; Humans; Psychotic Disorders; Schizophrenia | 1970 |
[On clinical experiences with Dapotum. (Preliminary communication)].
Topics: Aggression; Fluphenazine; Humans; Male; Psychotic Disorders; Schizophrenia | 1967 |
[Fluphenazine enanthate, delayed-action neuroleptic dru utilizable in outpatients treatment of chronic psychosis].
Topics: Ambulatory Care; Chronic Disease; Fluphenazine; Humans; Injections, Intramuscular; Psychotic Disorde | 1967 |
[Control treatment of chronic psychoses in ambulatory practice].
Topics: Fluphenazine; Humans; Psychotic Disorders | 1967 |
[Clinical therapeutic experiences with fluphenazine].
Topics: Acute Disease; Arteriosclerosis; Bipolar Disorder; Catatonia; Chronic Disease; Dementia; Depressive | 1967 |
[Management of psychotic drive disorders].
Topics: Adult; Bipolar Disorder; Chlorprothixene; Diazepam; Drive; Female; Fluphenazine; Humans; Imipramine; | 1968 |
[Experience in the management of chronic psychoses using fluphenazine-oenanthate].
Topics: Adolescent; Adult; Chronic Disease; Epilepsy; Female; Fluphenazine; Humans; Injections, Intramuscula | 1968 |
[On the problem of the therapeutical axis symptom of neuroleptic medicaments].
Topics: Adult; Extrapyramidal Tracts; Fluphenazine; Haloperidol; Handwriting; Humans; Male; Movement Disorde | 1968 |
Fluphenazine enanthate for the difficult psychotic patient.
Topics: Adult; Aged; Brain Damage, Chronic; Female; Fluphenazine; Hospitalization; Humans; Injections, Intra | 1969 |
[Fluphenazine HCl in psychiatry].
Topics: Adolescent; Adult; Female; Fluphenazine; Humans; Male; Middle Aged; Psychotic Disorders | 1965 |
Extreme sensitivity to phenothiazines in a psychotic patient with Pickwick syndrome.
Topics: Adolescent; Brain Stem; Chlorpromazine; Fluphenazine; Humans; Intellectual Disability; Male; Obesity | 1966 |
[Complementary neurolepsy].
Topics: Adult; Butyrophenones; Depression; Female; Fluphenazine; Humans; Male; Piperidines; Psychotic Disord | 1966 |
[Investigations on the psychological effects of fluphenazine in chronic psychoses].
Topics: Fluphenazine; Humans; Psychotic Disorders | 1966 |
[Fluphenazine enanthate in the treatment of chronic psychoses].
Topics: Adult; Female; Fluphenazine; Humans; Male; Middle Aged; Psychotic Disorders | 1966 |